#06 Next-Generation AI to cure Heart Disease, Cardiac Entrepreneur Animesh Agarwal

Heart disease is the leading cause of death worldwide.

Diagnosis - especially in its early stages - is difficult, costly & time-consuming.

Enter the power of AI.

Animesh Agarwal has been at the forefront of this burgeoning industry since 2019.

He founded NeuTrace, an AI-driven Cardiac electrophysiology platform - combining huge datasets to identify disease from abnormal heat rhythms. NeuTrace was then bought by Anumana to complement their own cardiac AI product suite, the company now making tremendous strides in the field.

Animesh talks about the new class of AI products that are emerging - products that don’t just improve what humans can already do; but products that do things we’ve never been able to.

Animesh & Anumana have been prolific in gaining FDA approval for their AI-driven products - 2 approved in the last year - and are harnessing the power of generative AI to achieve truly futuristic use-cases.

Hailing from an investment background, Animesh has tremendous knowledge of what makes a product successful in healthcare and medical devices. We discuss

• Animesh’s upbringing and what inspired him to get into healthcare
• Animesh’s experience in venture capital & his investment strategy
• Founding NeuTrace
• Advice on how to identify a product & market fit
• The future of AI - Anumana’s innovations

And much more!

https://www.linkedin.com/in/charlie-webb-a5605768/
https://www.linkedin.com/in/sumair-gill-086a151a1/